Basic Cardiovascular Sciences  /  GS06. Cardiac Metabolism in Health and Disease  /  Metabolomic Profiling of SLGT2 Inhibitors in Heart Failure
Logo

American Heart Association

  55
  0

Final ID:

Metabolomic Profiling of SLGT2 Inhibitors in Heart Failure

  • Shah, Svati  ( DUKE UNIV MEDICAL CENTER , Hillsborough , North Carolina , United States )
    • Author Disclosures:
    Svati Shah: DO have relevant financial relationships ; Research Funding (PI or named investigator):nference:Active (exists now) ; Other (please indicate in the box next to the company name):Unlicensed patent:Active (exists now) ; Research Funding (PI or named investigator):Verily, Inc.:Active (exists now) ; Research Funding (PI or named investigator):Lilly, Inc.:Past (completed) ; Research Funding (PI or named investigator):AstraZeneca:Active (exists now)
Meeting Info:

Basic Cardiovascular Sciences

2024

Chicago, Illinois

Session Info:

GS06. Cardiac Metabolism in Health and Disease

Tuesday, 07/23/2024 , 01:30PM - 02:45PM

General Session

More abstracts on this topic:
Targeting Cardiac Fatty Acid Oxidation to Treat HFpEF

Lopaschuk Gary

One Carbon Metabolism Defect In Failing Hearts

Jung Jae Woo, Flam Emily, Bedi Kenneth, Jang Cholsoon, Rabinowitz Joshua, Margulies Kenneth, Arany Zoltan

More abstracts from these authors:
Multi-Omics for Disentangling Clinical Heterogeneity: Heart Failure as a Paradigm

Ho Jennifer, Shah Sanjiv, Shah Svati

Proteomic biomarkers are associated with high-risk plaque phenotype and adverse events in the PROMISE trial

Karpurapu Anish, Kwee Lydia, De Calvacamp Caroline, Zhao Elizabeth, Nasir Khurram, Foldyna Borek, Douglas Pamela, Shah Svati

You have to be authorized to contact abstract author. Please, Login
Not Available